Mazda Launches Redesigned Corporate Website

HIROSHIMA, Japan, Oct 31, 2024 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation today launched a redesigned corporate website. Amid growing awareness and interest in sustainability, the company redesigned its website to provide stakeholders visiting the corporate website with more timely and user-friendly access to financial and non-financial data…

NTT and Toyota Motor Corporation agree to joint initiative in the field of mobility and AI/telecommunications with the aim of realizing a society with zero traffic accidents

Toyota City, Japan, Oct 31, 2024 - (JCN Newswire via SeaPRwire.com) - Today, Toyota Motor Corporation (hereafter, Toyota) and Nippon Telegraph and Telephone Corporation (hereafter, NTT) have agreed to a joint initiative in the field of mobility and AI/telecommunications with the aim of realizing a society with zero traffic accidents.Through…

Deltrix, a Subsidiary of Trio Group, Builds an In-depth Strategic Partnership with Haylion Technologies to Jointly Expand the New Energy Market

EQS Newswire / 31/10/2024 / 18:18 UTC+8 Deltrix, a Subsidiary of Trio Group, Builds an In-depth Strategic Partnership with Haylion Technologies to Jointly Expand the New Energy Market   [Hong Kong – 31 October 2024] EV Charger Solution Brand Deltrix by Trio Industrial Electronics Group Limited (“Trio Group”, Stock code:…

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

TOKYO and CAMBRIDGE, Mass., Oct 31, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc.  announced today that the latest findings for lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (Aβ) protofibril* antibody for the treatment of early Alzheimer’s disease (AD), were presented at the Clinical…

Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer’s Disease Conference (CTAD)

TOKYO, Oct 31, 2024 - (JCN Newswire via SeaPRwire.com) -  Eisai Co. Ltd announced today that the latest findings on anti-MTBR (microtubule binding region) tau antibody E2814 were presented at the 17th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, held in Madrid, Spain, and virtually. Eisai also announced initiation…

Analyzing Intel’s Stock Ahead of Earnings Release

As Intel Corporation (NASDAQ:INTC) prepares to release its earnings, Wall Street analysts offer differing opinions on the stock’s potential. Analysts are closely monitoring Intel's strategic shifts, particularly its focus on advancing chip technology to reclaim market share from rivals like AMD and Nvidia. The company's success in innovating and implementing…

Alphabet Reports Q3 2024 Earnings

Alphabet Inc., the parent company of Google, recently released its financial results for the third quarter of fiscal year 2024, providing insights into its financial performance and future strategies. The report highlighted key financial metrics, including revenue growth, net income, and operating margins. Alphabet's strong performance during this quarter was…